Chengda Pharmaceuticals Hits Day Low of CNY 35 Amid Price Pressure

Chengda Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 5.21% to touch an intraday low of CNY 35.00. This performance stands in contrast to the China Shanghai Composite, which recorded a modest gain of 0.59% for the day. Over the past week, Chengda's stock has shown a slight decrease of 0.03%, while its monthly performance reflects a significant increase of 27.7%, outperforming the broader market index, which rose by 2.58%. Year-to-date, however, the stock has faced challenges, with a decline of 12.78%, compared to the China Shanghai Composite's decrease of 1.42%. Despite these fluctuations, Chengda Pharmaceuticals has demonstrated a strong annual return of 15.3%, significantly higher than the market's 1.14%. The company's recent financial results indicate positive growth in pre-tax and net profits, with increases of 417.99% and 354.71%, respectively. However, the company faces concerns regarding management efficiency and long-term growth, as evidenced by a low return on capital employed and stagnant net sales growth over the past five years.